The artificial intelligence (AI)-designed peptide SK56 blocks mature gasdermin D pores, delaying pyroptosis and inflammatory cytokine release. This reduces dendritic cell hyperactivation and prevents the spread of pyroptosis to nearby cells. SK56 also protects against mitochondrial damage and improves survival in septic mice, demonstrating its potential as a new post-pyroptosis, anti-inflammatory therapy.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Shi, J. J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665 (2015). This paper identifies GSDMD as a substrate for inflammatory caspases and identifies its molecular mechanism in executing pyroptosis.
Wright, S. S. et al. Transplantation of gasdermin pores by extracellular vesicles propagates pyroptosis to bystander cells. Cell 188, 280–291.e17 (2024). This paper shows that pyroptosis can spread to neighboring cells through extracellular vesicles carrying GSDMD-NT pores, leading to the death of surrounding normal tissue cells.
Xia, S. Y. et al. Gasdermin D pore structure reveals preferential release of mature interleukin-1. Nature 593, 607–611 (2021). This paper reports the precise structural features of GSDMD-NT pores and identifies the functional regions responsible for the selective release of mature IL-1β.
Newton, K., Dixit, V. M. & Kayagaki, N. Dying cells fan the flames of inflammation. Science 374, 1076–1080 (2021). A review article that summarizes the roles of inflammatory responses, programmed cell death mechanisms, and their interplay with tissue injury and disease while exploring the importance of targeting cell death as a potential therapeutic strategy.
Cavaillon, J.-M., Singer, M. & Skirecki, T. Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Mol. Med. 12, e10128 (2020). A review article that discusses the challenges in sepsis translational research.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Sun, J. et al. Delaying pyroptosis with an AI-screened gasdermin D pore blocker mitigates inflammatory response. Nat. Immunol. https://doi.org/10.1038/s41590-025-02280-x (2025).
Rights and permissions
About this article
Cite this article
Precise inhibition of pyroptotic pores presents new opportunities for inflammation therapy. Nat Immunol 26, 1637–1638 (2025). https://doi.org/10.1038/s41590-025-02294-5
Published:
Issue date:
DOI: https://doi.org/10.1038/s41590-025-02294-5